Analyst Ratings for Cellebrite (CLBT)
CLBT Rating Summary
CLBT Price Target Summary
- Highest: $25.00 (BofA Securities)
- Lowest: $12.50 (Needham)
- Average: $17.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.50 (+47.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$17.50 (+47.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | DA Davidson » Updated 8/14/2026 |
Rudy Kessinger | New Coverage | Buy (N/A) |
15.00 (22.00) |
13.18 (11.85) |
-10.09% | Details |
| 4/19/2024 | Lake Street » Updated 8/14/2026 |
Eric Martinuzzi | New Coverage | Buy (N/A) |
15.00 (21.00) |
10.38 (11.85) |
14.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
